open access

Vol 14, No 1 (2019)
Editorial
Published online: 2009-04-10
Get Citation

Od Redaktora

Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2019.0017
·
Folia Cardiologica 2019;14(1).

open access

Vol 14, No 1 (2019)
Editorial
Published online: 2009-04-10

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Od Redaktora

Journal

Folia Cardiologica

Issue

Vol 14, No 1 (2019)

Published online

2009-04-10

DOI

10.5603/FC.2019.0017

Bibliographic record

Folia Cardiologica 2019;14(1).

Authors

Beata Wożakowska-Kapłon

References (7)
  1. Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma. Blood. 2015; 126(1): 17–25.
  2. Vu K, Ai W. Update on the treatment of anaplastic large cell lymphoma. Curr Hematol Malig Rep. 2018; 13(2): 135–141.
  3. Feyler S, Prince HM, Pearce R, et al. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant. 2007; 40(5): 443–450.
  4. Forero-Torres A, Leonard JP, Younes A, et al. A phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma. Br J Haematol. 2009; 146(2): 171–179.
  5. Mercadal S, Briones J, Xicoy B, et al. Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB). Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol. 2008; 19(5): 958–963.
  6. O'Connor OA, Horwitz S, Hamlin P, et al. Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies. J Clin Oncol. 2009; 27(26): 4357–4364.
  7. Schmitz N, Trümper L, Ziepert M, et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood. 2010; 116(18): 3418–3425.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl